These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 8150098

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 3. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.
    Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A.
    J Clin Endocrinol Metab; 1987 Sep; 65(3):499-507. PubMed ID: 3305551
    [Abstract] [Full Text] [Related]

  • 7. Role of sex-hormone-binding globulin and free sex steroid hormones in hyperandrogenic anovulation.
    Ohsawa M, Asai M, Masahashi T, Narita O, Tomoda Y, Matsui N.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2081-8. PubMed ID: 2947958
    [Abstract] [Full Text] [Related]

  • 8. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss.
    Pasquali R, Antenucci D, Casimirri F, Venturoli S, Paradisi R, Fabbri R, Balestra V, Melchionda N, Barbara L.
    J Clin Endocrinol Metab; 1989 Jan; 68(1):173-9. PubMed ID: 2642485
    [Abstract] [Full Text] [Related]

  • 9. Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease.
    Anttila L, Ding YQ, Ruutiainen K, Erkkola R, Irjala K, Huhtaniemi I.
    Fertil Steril; 1991 Jun; 55(6):1057-61. PubMed ID: 1903726
    [Abstract] [Full Text] [Related]

  • 10. [Insulin resistance and serum concentrations of ovarian and adrenal androgen in obese women without additional disease and with policystic ovary syndrome].
    Olszanecka-Glinianowicz M, Banaś M, Zahorska-Markiewicz B, Kuglin D, Mokrzycka J, Mentel A.
    Endokrynol Pol; 2005 Jun; 56(6):921-6. PubMed ID: 16821212
    [Abstract] [Full Text] [Related]

  • 11. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
    Vermeulen A, Kaufman JM, Giagulli VA.
    J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
    [Abstract] [Full Text] [Related]

  • 12. Induction of ovulation with spironolactone (Aldactone) in anovulatory oligomenorrheic and hyperandrogenic women.
    Evron S, Shapiro G, Diamant YZ.
    Fertil Steril; 1981 Oct; 36(4):468-71. PubMed ID: 6793406
    [Abstract] [Full Text] [Related]

  • 13. Anti-müllerian hormone and insulin-like 3 levels in healthy normal-weight ovulatory and anovulatory eumenorrheic late adolescent females: potential early biomarkers of ovarian dysfunction?
    Pelusi C, Stancampiano M, Fanelli F, Pariali M, Gambineri A, Pasquali R.
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():188-192. PubMed ID: 26579638
    [Abstract] [Full Text] [Related]

  • 14. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
    Arroyo A, Laughlin GA, Morales AJ, Yen SS.
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
    [Abstract] [Full Text] [Related]

  • 15. The decrease in luteinizing hormone secretion in response to weight reduction is inversely related to the severity of insulin resistance in overweight women.
    Bützow TL, Lehtovirta M, Siegberg R, Hovatta O, Koistinen R, Seppäla M, Apter D.
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3271-5. PubMed ID: 10999821
    [Abstract] [Full Text] [Related]

  • 16. An RCT of metformin versus orlistat for the management of obese anovulatory women.
    Metwally M, Amer S, Li TC, Ledger WL.
    Hum Reprod; 2009 Apr; 24(4):966-75. PubMed ID: 19095663
    [Abstract] [Full Text] [Related]

  • 17. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A, Mandeli J, Fluhr H, Dobrjansky A.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [Abstract] [Full Text] [Related]

  • 18. Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men.
    Pasquali R, Casimirri F, De Iasio R, Mesini P, Boschi S, Chierici R, Flamia R, Biscotti M, Vicennati V.
    J Clin Endocrinol Metab; 1995 Feb; 80(2):654-8. PubMed ID: 7852532
    [Abstract] [Full Text] [Related]

  • 19. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
    Adams JM, Taylor AE, Crowley WF, Hall JE.
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
    [Abstract] [Full Text] [Related]

  • 20. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
    Insler V, Barash A, Shoham Z, Koistinen R, Seppala M, Hen M, Lunenfeld B, Zadik Z.
    Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.